K.G. Jebsen Center for Autoimmune Diseases
Autoimmune diseases affect hundreds of millions of people worldwide with chronic disorders, vital organ failure and premature death in the same condition as cancer and heart disease. An autoimmune disease may affect one or more organs or tissues and a person may have more autoimmune diseases at the same time.
Today’s treatment is limited to replacement therapy and the use of anti-inflammatory drugs, which do not provide full-bodied health, but reduced quality of life and higher risk of premature death. K. G. Jensen Center for Autoimmune Diseases presents a new method for finding causes of autoimmunity with the aim of finding new diagnostic methods and person-based treatments based on this knowledge. With the expertise the center holds, both from the University of Bergen, Helse Bergen and national and international partners, the Center has the potential to take an international leadership role in the work on this important topic.
Expert in clinical and experimental endocrinology and autoimmunity, with a track record in identification of genetic variants and autoantigens as well as clinical and registry studies.
(PI, deputy director) – UiB, an expert in molecular biology and functional studies of genetic disorders in autoimmunity.
(PI, deputy director) – HUS, a clinical endocrinologist with vast experience in epidemiology, clinical trials, and patient registries.
(PI) – KI, a world-leading expert in molecular medicine within the field of endocrinology and immunology; member of The Royal Swedish Academy of Science and The Nobel Prize Committee. Excellent track record in identification of novel autoantigens, clinical and registry studies as well as comparative genetics (dogs, chickens).
a world-leading expert in genomics and bioinformatics with an excellent track record in identifying novel monogenic diseases.
(PI) – UiB, an expert in developing new immunomodulatorytherapies in leukemia; he will play a key role in designing new immune therapies.
(PI) – UiB, an expert in experimental autoimmunity using in vitro cell systems and animal models for the study of pathogenesis.
(PI) – UiB, an expert in molecular biology and functional studies of genetic disorders in autoimmunity, recently characterized a new form of APS.
(collaborator) – The Weizmann Institute of Science, a leading expert in autoimmune animal models related to immunological tolerance, especially in mouse models. User of CRISPR/Cas9 technology to generate mouse models.
Mediaomtale
- MorgenbladetNår antistoffene vender seg mot deg25.11.2020
- UiB.noGenetiske risikofaktorer for autoimmun Addisons sykdom15.10.2020
- Forskning.noSjelden immunsviktsykdom kan gjøre unge alvorlig syke av koronaviruset11.10.2020
- Verdens GangNy corona-forskning: Derfor blir noen unge alvorlig syke5.10.2020
- UiB.noSvikt i immunsystemet kan gi alvorlig covid-19-sykdom5.10.2020
- Bergens TidendeGeir har levd i nesten 50 år med kronisk sykdom. Nå overrasker han forskerne11.8.2020
- NRK VitenLovande MS-forsking9.7.2020
- Helse Bergen.noGir håp til pasienter med autoimmune sykdommer21.5.2019
- Litteraturhuset i BergenKroppen for voksne: Når kroppen angriper seg selv13.2.2019
- DoktoronlineHar du en autoimmun sykdom?19.12.2018
- UiB.noJulekalender sammen med ROASdesember 2018
- På HøydenUiB får senter for autoimmune sykdommer27.2.2017:
- A-magasinetHva skjer når kroppen angriper seg selv?2.11.2017
- Forskning.noVonde opplevelser økte risiko for autoimmun sykdom10.10.2017
- UiB.noUiB åpnet K.G. Jebsen senter for autoimmune sykdommer18.8.2017
About the centre
Centre leader: Eystein S. Husebye
Startup: 2017
Host insitution: University of Bergen
Funding: 18 MNOK
Homepage
Centre contact information
K. G. Jebsen Center for Autoimmune Diseases
University of Bergen
Jonas Liesvei 91B, 8. floor Laboratorieblokken
Klinisk institutt 2
5021 Bergen
Email: lars.breivik@uib.no
Phone: + 47 55 97 30 77
Scientific advisory board
Graham Anderson, University of Birmingham
Leif Anderson, Uppsala University
Adrian Liston, University of Leuven
